The mainstream media is continuing to report on the rapid spreading of the “pirola” variant. Pirola, or BA.2.86, is the third most prevalent COVID strain in the United States, and although there may be concerns among the control system that the new monovalent “vaccines” do not offer any protection against it.
Pirola is circulating the most in the Northeast, where it’s the second most common variant in the region (13%) after HV.1. According to a report by Forbes, Pirola joined four other variants as “variants of interest” by the World Health Organization on Monday, a step up from its “variant under monitoring” label in August.
While constantly fear-mongering the new variant, the mainstream media also cited the Centers for Disease Control and Prevention, saying that the “public health risk posed by this variant is low.” According to further comments by the CDC, the updated vaccines are expected to increase protection against Pirola.
Not oddly enough, this whole thing always comes back to trying to convince the public to be injected with whatever is in the so-called COVID-19 vaccines.
Others say that the “vaccines” are going to help create more offshoots of Pirola.
Some experts aren’t so sure Pirola and its offsprings—most notably JN.1—will be very protected under the new vaccines. The authors of a bioRxiv study wrote in a pre-publication comment, which hasn’t yet been peer-reviewed, that the newer vaccines could spur the spread of the more recent Pirola viruses. –Forbes
It’s still unknown whether Pirola causes different symptoms than other variants, according to the CDC. Pirola is a part of the Omicron family and is a highly mutated offshoot of its parent variant BA.2, which was the dominant strain in 2022 and made up 85% of cases in April 2022. JN.1, one of Pirola’s mutations, has rapidly spread in other countries. It was first detected in the U.S. in September and has been found in at least 11 countries, according to the CDC.
It’s hard to say right now just how far the mainstream media will take the fear-mongering over these new variants.